The service uses cookies!
Allow us to collect cookies so we can tailor content to your needs. You agree to this by continuing to browse the site
Thank You for Visiting US at Premier Breakthroughs 2025!
Our team had a fantastic time connecting with healthcare professionals and industry leaders at Premier Breakthroughs, held July 15–17 in National Harbor, MD.
A heartfelt thank you to everyone who visited Booth #1311 to explore our innovative Medication Delivery and Blood Collection solutions. Your interest and conversations inspire our continued commitment to advancing injection safety and patient care.
We had an incredible turnout at our latest InsuJet™ event, held in Burlington!
A big thank you to the Burlington Post for coming out to cover the event and sharing our mission of transforming diabetes care with needle-free solutions.
Special appreciation to Chris Jarvis for joining us, and to Shana, one of our amazing T2 patients, who shared her inspiring story about the lifestyle benefits of transitioning to a needle-free option like InsuJet™.
These moments are a reminder of why we do what we do.
Sol M had the pleasure of connecting with pharmacists and healthcare professionals across Western Canada this past weekend! A big thank you to the London Drug Team and our very own Daphne Lapenna for making it all happen!
We were excited to introduce the InsuJet™, our needle-free insulin delivery system, and demonstrate how it’s helping transform diabetes care.
Thank you to everyone who stopped by our table to learn more and share your feedback. We truly value the opportunity to engage with the incredible London Drugs Pharmacy network.
Until next time!
Daphne Lapenna, SOL M’s National Director of Pharmacy Partnerships, was thrilled to attend Save-On-Pharmacy’s Western conferences, "Navigating the Healthcare Horizon," held in Edmonton and Vancouver. These events provided a platform to introduce InsuJet™, Canada’s first needle-free insulin delivery device, to Pharmacy Managers.
For those unable to attend, Daphne hosted a remote session on Saturday, May 10th, connecting with over 50 pharmacists.
A heartfelt thank you to all the Pharmacy Managers and the Pattison Food Group Head Office team for their warm reception and unwavering support in successfully launching InsuJet™. Together, we’re excited to empower Western Canadians living with diabetes and support Save-On-Pharmacy patients as they embark on their needle-free journeys.
Daphne Lapenna and Chris Sekema from the Sol-Millennium team had an amazing time at the annual Pharmasave Conference in gorgeous Vancouver, April 29th to 30th. They were thrilled to introduce Pharmasave to InsuJet™—the first needle-free insulin delivery device in Canada—once again this year.
It was great to share updates about InsuJet’s growing availability across Canada through McKesson and the exciting introduction of Pharmacy Education Fees. The momentum is undeniable, and it’s inspiring to see how InsuJet™ is making a real difference for Canadians living with diabetes.
A huge thank-you to the Pharmasave National Team for their incredible support! We’re excited to continue working closely with both the national and regional offices to support their members across Canada and bring meaningful advancements to diabetes care.
Special thanks to PharmaChoice for hosting another successful pharmacy conference!
As always, it’s a pleasure for our team to meet face to face with pharmacists and clinicians. Sol-Millennium is excited about the future of needle-free insulin delivery, and we look forward to continuing the conversations.
On behalf of the Sol-Millennium Diabetes Portfolio Team, we would like to extend our gratitude to Khalid Bhatti, Dr. Rishi Handa, and the entire clinical team for including InsuJet™ in the 2nd annual Durham Care Diabetes Symposium, held in collaboration with Diabetes Canada. During the event, InsuJet™ was showcased as an innovative needle-free insulin delivery technology to an audience of over 200 primary care physicians and clinicians.
A special thank you also goes out to Susie Jin, recently welcomed by Sol M as a Key Opinion Leader, for presenting the latest updates to the 2025 Diabetes Clinical Practice Guidelines. We are excited to support the clinicians who attended the symposium and their patients as they explore the benefits of needle-free insulin delivery.